PMID: 8613628Mar 1, 1996Paper

Urinary leukotriene E4 in the assessment of nocturnal asthma

The Journal of Allergy and Clinical Immunology
V BelliaG Bonsignore

Abstract

Urinary leukotriene E4 (LTE4) is a marker of the body's production of cysteinyl LTs, important mediators of airway inflammation. The role of the latter in nocturnal asthma is a topic of increasing interest. This investigation was aimed at determining whether nighttime attacks are associated with increased release of LTs, expressed by urinary LTE4, and the relationship between the two phenomena. Three groups were studied: group A, seven control subjects; group B, nine asthmatic patients without nocturnal attacks; and group C, nine asthmatic patients with a comparable daytime FEV1 but who were experiencing nocturnal exacerbations (morning dips in peak expiratory flow greater than 20%). Urine was collected over 24 hours in three samples (9:00 AM to 3:00 PM; 3:00 PM to 9:00 PM; and 9:00 PM to 9:00 AM). LTE4 was measured by high-performance liquid chromatography and radioimmunoassay and expressed as nanograms per millimole of creatinine. No significant differences between urinary LTE4 were noticed within groups A and B. Conversely, in group C urinary LTE4 at night (geometric mean with 95% confidence interval; 35.16 with 28.77-42.85) was significantly higher than that of the other samples (respectively 23.12 with 17.78-30.06, p less ...Continue Reading

Citations

Aug 2, 2000·Pediatric Pulmonology·H Bisgaard
Aug 7, 1999·Clinical Reviews in Allergy & Immunology·J Y Westcott
May 13, 2004·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Berrylin J Ferguson
Nov 4, 2000·Prostaglandins & Other Lipid Mediators·N SuzukiM Mizugaki
Nov 26, 2003·Respiratory Medicine·Isabelle VachierPascal Chanez
Nov 30, 2006·Current Opinion in Pulmonary Medicine·Hidenobu Shigemitsu, Kamyar Afshar
Sep 10, 1998·American Journal of Respiratory and Critical Care Medicine·R J Martin, S Banks-Schlegel
Jan 5, 1999·American Journal of Respiratory and Critical Care Medicine·M KraftS T Holgate
Feb 15, 2000·American Journal of Respiratory and Critical Care Medicine·M Kumlin
Mar 17, 2004·Clinical and Molecular Allergy : CMA·Giorgio CiprandiAndrea Vizzaccaro
Nov 19, 2003·American Journal of Veterinary Research·Carol R NorrisLaurel J Gershwin
Mar 1, 2011·Annales Françaises D'anesthèsie Et De Rèanimation·D Laroche, B Debaene
Oct 8, 1999·Chronobiology International·M Kraft
Aug 11, 2012·Immunology and Allergy Clinics of North America·Nathan Rabinovitch
Nov 13, 2007·Immunology and Allergy Clinics of North America·Nathan Rabinovitch
Apr 15, 2004·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·N L A MissoP J Thompson
Jul 16, 2003·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H MechicheP Devillier
Sep 17, 2013·International Forum of Allergy & Rhinology·Jeremiah A Alt, Timothy L Smith
Jul 15, 2004·Respiratory Medicine·E BucchioniS A Kharitonov
Oct 21, 2006·Current Opinion in Pulmonary Medicine·Lesley Woods, Timothy J Craig
Dec 11, 1999·Proceedings of the Association of American Physicians·J M Drazen
Feb 13, 2001·Pulmonary Pharmacology & Therapeutics·S NicosiaG E Rovati
Jan 18, 2003·The Journal of Allergy and Clinical Immunology·Anthony P SampsonHans Bisgaard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.